Enzymatica AB: ColdZyme study - Most recommended cold product at pharmacies
November 09 2017 - 2:00AM
News
Lund, November 9, 2017
ColdZyme study - Most recommended
cold product at pharmacies
A new market survey shows that
ColdZyme® Mouth Spray is the cold product that
pharmacy staff in Sweden recommend most[1].
The majority of consumers who asked for help and
recommendations at the pharmacy regarding colds were advised to use
ColdZyme. In addition, recent statistics from Nielsen Data show
that ColdZyme is the most successful brand
launch of a new cold product[2] in over 30 years. The product has
achieved a market share of 5 % (value) in the cold category since
its launch in Sweden in 2013.
Market research company GfK was commissioned by
Enzymatica to conduct a market survey at 93 pharmacies in the
Stockholm, Gothenburg and Skåne metropolitan areas. "Mystery
shoppers" who pretended to be consumers with symptoms that included
feeling sick and a sore throat asked pharmacy staff to recommend
something that could help with a cold. ColdZyme was the product
recommended more often than other cold products to prevent and
shorten the duration of a cold. ColdZyme was recommended by 67
percent of pharmacy staff, while only 26 percent recommended the
product that received the second highest number of votes. The
results are statistically significant.
-
Spraying in the mouth and throat causes a
protective barrier to form on the mucosa. The barrier captures the
cold virus and deactivates the ability of the virus to infect
cells, which protects the throat and allows the body to rid itself
of the virus naturally," says Fredrik Lindberg, CEO of
Enzymatica.Typical occasions when the risk of being infected with
colds increases include large family gatherings, train and air
travel, at work in an open office landscape, or during typical cold
periods such as the end of vacation, the start of school or the
winter holiday season.
-
Using the spray for prevention when you are
exposed to an increased risk of contamination makes it possible to
prevent a cold from breaking out. And if you've already caught a
cold, the duration of disease can be reduced by using ColdZyme,"
says Fredrik Lindberg.
Of the 5 best-selling brands within colds,
ColdZyme is the only completely new brand to be launched in over 30
years. ColdZyme currently has a market share of 5 % (value), and is
also the 5th best-selling brand in Sweden that is sold in the cold
category in Swedish pharmacies (Nielsen Data, 20170930).
Enzymatica has conducted a number of user studies,
including studies in which elite athletes and preschool and elder
care staff have used ColdZyme. The results show findings such as a
significant reduction in the number of sickness absence days and
milder cold symptoms when participants in the studies did catch
colds.
For
more information, please contact:
Fredrik Lindberg, CEO, Enzymatica AB
Tel: +46 (0)708-86 53 70 | Email:
fredrik.lindberg@enzymatica.com
About Enzymatica AB
Enzymatica AB is a Swedish life science company that develops and
sells medical devices for infection-related diseases. The products
are based on a barrier technology that includes marine enzymes. The
company's first product is ColdZyme® Mouth Spray, which can prevent
colds and reduce the duration of disease. The product has been
launched in about ten markets. The strategy is to continue to grow
by strengthening the Company's position in existing markets and
expanding into new geographic markets through established partners.
The company has its headquarters in Lund and is listed on Nasdaq
First North. For more information,
visit: www.enzymatica.se.
Enzymatica's certified adviser is Erik Penser
Bank.
About Mystery
Shopping
The © GfK Mystery Shopping and Attitudinal Study was conducted in
April and May 2017. A total of 93 pharmacies were visited in the
Stockholm, Gothenburg and Skåne metropolitan areas. The mystery
shopper presented with symptoms such as feeling sick and/or a sore
throat and asked for a product that could help. Mystery Shopping
conducted by GfK shows that ColdZyme is recommended by pharmacists
significantly (P <0.001) more often than other cold products to
prevent or reduce the duration of a cold.
[1] © GfK
Mystery Shopping and Attitudinal Study | May 2017
[2] Nielsen
Data, 12M MAT, 20170930
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Enzymatica AB via Globenewswire
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024